Your browser doesn't support javascript.
loading
Antigen-Specific CD4+ T-Cell Activation in Primary Antibody Deficiency After BNT162b2 mRNA COVID-19 Vaccination.
Sauerwein, Kai M T; Geier, Christoph B; Stemberger, Roman F; Akyaman, Hüseyin; Illes, Peter; Fischer, Michael B; Eibl, Martha M; Walter, Jolan E; Wolf, Hermann M.
Afiliação
  • Sauerwein KMT; Immunology Outpatient Clinic, Vienna, Austria.
  • Geier CB; Department for Biomedical Research, Center of Experimental Medicine, Danube University Krems, Krems an der Donau, Austria.
  • Stemberger RF; Biomedizinische Forschung & Bio-Produkte AG, Vienna, Austria.
  • Akyaman H; Immunology Outpatient Clinic, Vienna, Austria.
  • Illes P; Immunology Outpatient Clinic, Vienna, Austria.
  • Fischer MB; Immunology Outpatient Clinic, Vienna, Austria.
  • Eibl MM; USF Health Department of Pediatrics, Division of Allergy/Immunology, Children´s Research Institute, St. Petersburg, FL, United States.
  • Walter JE; Department for Biomedical Research, Center of Experimental Medicine, Danube University Krems, Krems an der Donau, Austria.
  • Wolf HM; Clinic for Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Front Immunol ; 13: 827048, 2022.
Article em En | MEDLINE | ID: mdl-35237272

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Doenças da Imunodeficiência Primária / SARS-CoV-2 / COVID-19 / Vacina BNT162 Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Doenças da Imunodeficiência Primária / SARS-CoV-2 / COVID-19 / Vacina BNT162 Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article